on news

footer news ticker

SUCCESSFUL PLACEMENT: LANTHEUS MEDICAL IMAGING - VP, HEAD OF GLOBAL DEFINITY FRANCHISE | ON Partners

resources.

SUCCESSFUL PLACEMENT: LANTHEUS MEDICAL IMAGING – VP, HEAD OF GLOBAL DEFINITY FRANCHISE

Sep 21, 2020 | Diversity, Steve Cornacchia, Successful Placements

Gerard Hernandez named new Lantheus Medical Imaging VP, Head of Global DEFINITY Franchise

 


Lantheus Holdings, Inc. (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture and commercialization of innovative diagnostic and therapeutic agents and products, has appointed Gerard Hernandez to Vice President, Head of Global DEFINITY Franchise.

Gerard joins Lantheus Medical Imaging from a tenured career at Sunovion Pharmaceuticals where he most recently served as Executive Director, Respiratory Marketing. At Sunovion, Gerard led the respiratory franchise including nebulized and handheld products in various stages of life from launch, growth, maintenance and LOE.

Gerard holds a Bachelor’s degree in Finance from Morehouse College, and earned his MBA in Marketing and Finance from Emory University – Goizueta Business School.

ON Partners consultant Steve Cornacchia is proud to have partnered with Lantheus Medical Imaging and Gerard Hernandez on this successful placement. Read more about ON Partners recent Life Sciences and Healthcare results, including our placement on the Top 50 Life Sciences and Healthcare industry rankings.


About Lantheus Medical Imaging

 

Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture and commercialization of innovative diagnostic and therapeutic agents and products. Lantheus provides a broad portfolio of products, including the echocardiography agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; AZEDRA® for the treatment of certain rare neuroendocrine tumors; and RELISTOR® for the treatment of opioid-induced constipation, which is partnered with Bausch Health Companies, Inc. The Company is headquartered in North Billerica, Massachusetts with offices in New York, New Jersey, Puerto Rico, Canada and Sweden. For more information, visit www.lantheus.com.

 


About ON Partners

 

ON Partners propels an organization’s mission by building C-level and board leadership teams. Founded in 2006 by like-minded consultants as a values-driven alternative to the multi-service global firms they were leaving behind, ON delivers a better executive search experience. Named by Forbes as one of America’s Best Executive Recruiting Firms and to the Inc. 500/5000 Lists seven times, the firm is consistently ranked among the top 20 retained executive search firms in the U.S.

Follow our work, updates and recent success on Twitter and LinkedIn.

Find our related successful placements of leading financial executives here.

Archives